Peripheral γδ T-lymphocytes as an innovative tool in immunotherapy for metastatic renal cell carcinoma
Data up to Jan 2025
Total Citations Per Year
Abstract
References (83)
Tumour-educated macrophages promote tumour progression and metastasis
2004 • 3,259 citations
Cancer immunotherapy: moving beyond current vaccines
2004 • 2,932 citations
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
2002 • 2,781 citations
Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.
1995 • 1,320 citations
Isoprenoid biosynthesis in bacteria: a novel pathway for the early steps leading to isopentenyl diphosphate
1993 • 1,158 citations
Recognition of Stress-Induced MHC Molecules by Intestinal Epithelial γδ T Cells
1998 • 1,134 citations
γδ Cells: A Right Time and a Right Place for a Conserved Third Way of Protection
2000 • 1,107 citations
Natural and synthetic non-peptide antigens recognized by human γδ T cells
1995 • 974 citations
Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma
1998 • 962 citations
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells
2005 • 916 citations
Classification of renal cell carcinoma
1997 • 887 citations
Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma
2004 • 801 citations
Human T Cell Receptor γδ Cells Recognize Endogenous Mevalonate Metabolites in Tumor Cells
2003 • 782 citations
Stimulation of Human γδ T Cells by Nonpeptidic Mycobacterial Ligands
1994 • 685 citations
Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo
1995 • 672 citations
Professional Antigen-Presentation Function by Human γδ T Cells
2005 • 668 citations
Regression of human metastatic renal cell carcinoma after vaccination with tumor cell–dendritic cell hybrids
2000 • 652 citations
Stimulation of γδ T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma
2000 • 630 citations
SYSTEMIC THERAPY FOR RENAL CELL CARCINOMA
2000 • 610 citations
γδ T cells for immune therapy of patients with lymphoid malignancies
2003 • 525 citations
Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire.
1990 • 510 citations
Novel mutations of the MET proto-oncogene in papillary renal carcinomas
1999 • 502 citations
Prominence of γδ T cells in the ruminant immune system
1991 • 427 citations
Renal cell carcinoma.
2006 • 382 citations
Human γδ T Cells Recognize Alkylamines Derived from Microbes, Edible Plants, and Tea
1999 • 368 citations
Self-Recognition of Cd1 by γ/δ T Cells
2000 • 367 citations
Randomized phase III trial of the Raf kinase and VEGFR inhibitor sorafenib (BAY 43–9006) in patients with advanced renal cell carcinoma (RCC)
2005 • 358 citations
Recognition by Human V γ 9/V δ 2 T Cells of a GroEL Homolog on Daudi Burkitt's Lymphoma Cells
1990 • 357 citations
Identification of (E)‐4‐hydroxy‐3‐methyl‐but‐2‐enyl pyrophosphate as a major activator for human γδ T cells in Escherichia coli
2001 • 330 citations
Implication of γδ T cells in the human immune response to cytomegalovirus
1999 • 316 citations
Tumor Recognition following Vγ9Vδ2 T Cell Receptor Interactions with a Surface F1-ATPase-Related Structure and Apolipoprotein A-I
2005 • 281 citations
Phase iii randomized trial of interleukin-2 with or without lymphokine-activated killer cells in the treatment of patients with advanced renal cell carcinoma
1995 • 278 citations
V gamma 2V delta 2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer.
1995 • 276 citations
Genetic Basis of Cancer of the Kidney
2004 • 247 citations
Structure of a human γδ T-cell antigen receptor
2001 • 243 citations
Patterns of Human Tumor-Infiltrating Lymphocytes in 120 Human Cancers
1990 • 240 citations
Induction of γδ T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo
2003 • 239 citations
Multicenter, Randomized, Phase III Trial of CD8+ Tumor-Infiltrating Lymphocytes in Combination With Recombinant Interleukin-2 in Metastatic Renal Cell Carcinoma
1999 • 212 citations
Vγ9Vδ2 T Cell Response to Colon Carcinoma Cells
2005 • 194 citations
In Vivo Immunomanipulation of Vγ9Vδ2 T Cells with a Synthetic Phosphoantigen in a Preclinical Nonhuman Primate Model
2005 • 187 citations
Phosphostim-Activated γδ T Cells Kill Autologous Metastatic Renal Cell Carcinoma
2005 • 179 citations
Phase 1 Study in Patients With Metastatic Melanoma of Immunization With Dendritic Cells Presenting Epitopes Derived From the Melanoma-Associated Antigens MART-1 and gp100
2000 • 179 citations
Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas
2005 • 168 citations
Human γδ T Cells Induce Dendritic Cell Maturation
2002 • 166 citations
Recombinant alfa interferon in renal cell carcinoma: a randomized trial of two routes of administration.
1987 • 165 citations
Patterns of Chemokine Receptor Expression on Peripheral Blood γδ T Lymphocytes: Strong Expression of CCR5 Is a Selective Feature of Vδ2/Vγ9 γδ T Cells
2002 • 152 citations
Characterization of Tumor Reactivity of Human Vγ9Vδ2 γδ T Cells In Vitro and in SCID Mice In Vivo
2004 • 150 citations
Chemical Synthesis and Biological Activity of Bromohydrin Pyrophosphate, a Potent Stimulator of Human γδ T Cells
2001 • 148 citations
Targeting of Tumor Cells for Human γδ T Cells by Nonpeptide Antigens
2001 • 146 citations
Spontaneous regression of metastases of renal cancer: A report of two cases including the first recorded regression following irradiation of a dominant metastasis and review of the world literature
1981 • 145 citations
Lymphotoxin-Mediated Regulation of γδ Cell Differentiation by αß T Cell Progenitors
2004 • 143 citations
Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention
2000 • 132 citations
Close correlation between Daudi and mycobacterial antigen recognition by human gamma delta T cells and expression of V9JPC1 gamma/V2DJC delta-encoded T cell receptors.
1993 • 131 citations
Plasmodium falciparum stimuli for human gammadelta T cells are related to phosphorylated antigens of mycobacteria
1996 • 131 citations
Interleukin-2 with or without LAK cells in metastatic renal cell carcinoma: a report of a European multicentre study.
1989 • 109 citations
Vγ9/Vδ2 T cell activation induced by bacterial low molecular mass compounds depends on the 1-deoxy-d-xylulose 5-phosphate pathway of isoprenoid biosynthesis
1999 • 94 citations
EX VIVO EXPANDED HUMAN Vλ9Vδ2+ λδ-T CELLS MEDIATE INNATE ANTITUMOR ACTIVITY AGAINST HUMAN PROSTATE CANCER CELLS IN VITRO
2005 • 91 citations
Recovery of CD8+ T-Cell Function During Systemic Chemotherapy in Advanced Ovarian Cancer
2005 • 82 citations
A chemical basis for recognition of nonpeptide antigens by human γδ T cells*
2000 • 80 citations
Human Vγ2Vδ2 T Cells Produce IFN-γ and TNF-α with an On/Off/On Cycling Pattern in Response to Live Bacterial Products
2001 • 80 citations
Sensing cell stress and transformation through Vγ9Vδ2 T cell-mediated recognition of the isoprenoid pathway metabolites
2005 • 80 citations
Gamma /delta T cells provide innate immunity against renal cell carcinoma
2001 • 78 citations
Killing of Laminin Receptor-Positive Human Lung Cancers by Tumor-Infiltrating Lymphocytes Bearing γδ + T-Cell Receptors
1996 • 64 citations
Anti-tumor effects of human peripheral ?? T cells in a mouse tumor model
2001 • 64 citations
Placebo‐associated remissions in a multicentre, randomized, double‐blind trial of interferon γ‐1b for the treatment of metastatic renal cell carcinoma
2000 • 58 citations
In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
1997 • 54 citations
Immunotherapy with interleukin-2 (IL2) and lymphokine-activated natural killer cells: Improvement of clinical responses in metastatic renal cell carcinoma patients previously treated with IL2
1994 • 54 citations
Escherichia coli Produces Phosphoantigens Activating Human γδ T Cells
2002 • 51 citations
Renal cell carcinoma
2001 • 51 citations
Human γδ T Lymphocytes Exert Natural and IL–2–Induced Cytotoxicity to Neuroblastoma Cells
2000 • 50 citations
Antilymphoma activity of human gamma delta T-cells in mice with severe combined immune deficiency.
1992 • 49 citations
The genetic basis of renal cell carcinoma
2003 • 45 citations
New treatments for metastatic kidney cancer.
2005 • 36 citations
Vδ2+ γδ T Lymphocytes Are Cytotoxic to the MCF 7 Breast Carcinoma Cell Line and Can Be Detected among the T Cells That Infiltrate Breast Tumors
1993 • 35 citations
A simple method for the propagation and purification of γδT cells from the peripheral blood of glioblastoma patients using solid-phase anti-CD3 antibody and soluble IL-2
1997 • 32 citations
Specific Activation of Human Peripheral Blood γ/δ+ T Lymphocytes by Sonicated Antigens of Mycobacterium tuberculosis: Role In Vitro in Killing Human Bladder Carcinoma Cell Lines
1993 • 28 citations
Early Expression of a Functional TCRβ Chain Inhibits TCRγ Gene Rearrangements without Altering the Frequency of TCRγδ Lineage Cells
2004 • 25 citations
Skewing of cytotoxic activity and chemokine production, but not of chemokine receptor expression, in human type-1/-2 γ δ T lymphocytes
2002 • 20 citations
High-Dose Interleukin-2 Two Days a Week for Metastatic Renal Cell Carcinoma
1994 • 14 citations
Phase I clinical trial of BromoHydrin PyroPhosphate, BrHPP (Phosphostim), a Vγ9Vδ2 T lymphocytes agonist in combination with low dose Interleukin-2 in patients with solid tumors
2005 • 11 citations
The Identification of Renal Cell Carcinoma as a Target for Allogeneic Based Cancer Immunotherapy
2002 • 10 citations
Lymphadenectomy for renal cell carcinoma
2005 • 7 citations
Deleted Work
1955 • 0 citations
Cited By (0)
No citing papers found in database